Troax builds research labs for Sygnature
Project is part of a £1m expansion at BioCity, Nottingham, UK
Sygnature provides medicinal chemistry research services to biotechnology and pharmaceutical companies from BioCity, which, as home to more than 60 businesses, is the UK’s largest bioscience innovation centre.
Troax used its Toledo partitioning system to construct the new research laboratories, as well as a suite of offices and a boardroom. Double-glazed panels ensure a light and pleasant working environment for staff, while sets of single and double doors, all with vision panels, have also been fitted. The project was carried out in association with Cleanroom Design and Construction.
Toledo’s modular design provided the flexibility needed to build this complex layout of 14 separate laboratory areas and offices covering 300m2. The panels also encased building columns, pipes and other services.
Sygnature Chemical Services says it also liked the versatility offered by Toledo’s modular design as it gives the option to alter or extend the layout of the area in the future with minimum disruption or cost.
Toledo partitioning is produced in a steel, monobloc construction and uses an inert non-particle shedding infill finish. To prevent the collection of particles and ensure easy-to-clean, smooth surfaces, Toledo is coated in powder paint and has a two-line panel junction and flush line double glazing, resulting in minimal ledges and corners.
Troax also used its one-hour fire-rated Excalibur double skin steel partitioning to construct a chemical storage facility within the laboratory. Also modular in design, Excalibur ensures the safe storage of the potentially flammable materials. The panels meet the fire resistance integrity criteria specified in BS: 476, Part 22: 1987 for a period of 60 minutes.
You may also like
Trending Articles
You may also like
Research & Development
Biocytogen - innovative solutions for cleanroom
Technological innovation in the field of biomedicine has made rapid progress, which has brought about changes and improvements in the development of new drugs and the treatment of diseases. In particular, the emerging innovative therapies such as gene therapy and cell therapy have achieved new breakthroughs in the treatment of rare diseases and tumors. More and more new therapies and innovative drugs are moving from the laboratory to the clinic, and one of the indispensable tools to the clinic are the experiment animals